Chemical Component Summary

NameGENISTEIN
Identifiers5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one
FormulaC15 H10 O5
Molecular Weight270.24
TypeNON-POLYMER
Isomeric SMILESOc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O
InChIInChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H
InChIKeyTZBJGXHYKVUXJN-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count30
Chiral Atom Count0
Bond Count32
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB01645 
NameGenistein
Groupsinvestigational
DescriptionAn isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines. Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in <I>Felmingia vestita</I>, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode. Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women [A14417]. Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin.
Synonyms
  • 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
  • Genistein
  • 5,7,4'-trihydroxyisoflavone
  • Genisteol
  • Genisterin
Brand Names
  • Vp-gstn
  • Fosteum
IndicationCurrently Genistein is being studied in clinical trials as a treatment for prostate cancer.
Categories
  • Anticarcinogenic Agents
  • Antineoplastic Agents
  • BCRP/ABCG2 Inhibitors
  • Benzopyrans
  • Chromones
CAS number446-72-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Estrogen receptor betaMDIKNSPSSLNSPSSYNCSQSILPLEHGSIYIPSSYVDSHHEYPAMTFYS...unknown
DNA topoisomerase 2-alphaMEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTY...unknown
Protein-tyrosine kinase 2-betaMSGVSEPLSRVKLGTLRRPEGPAEPMVVVPVDVEKEDVRILKVCFYSNSF...unknown
Nuclear receptor coactivator 1MSGLGDSSSDPANPDSHKRKGSPCDTLASSTEKRRREQENKYLEELAELL...unknown
Estrogen receptor alphaMTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPA...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682